Major Pharmaceuticals Recalls Chlorpromazine Hydrochloride Tablets Due to Hazardous Chemical
Major Pharmaceuticals recalled 506 blister packs of Chlorpromazine Hydrochloride tablets on September 12, 2025. The recall stems from CGMP deviations due to the presence of N-Nitroso Desmethyl Chlorpromazine above safe limits. Consumers should stop using the product immediately and consult healthcare providers.
Product Details
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 50 mg, packaged in 100 tablet blister packs. The affected lots are N02009 and N02026 with an expiration date of February 28, 2026. The product was distributed nationwide.
The Hazard
The recall was initiated due to CGMP deviations. N-Nitroso Desmethyl Chlorpromazine levels exceeded the recommended intake limit.
Reported Incidents
No specific incidents or injuries have been reported in relation to the recalled product. The potential risk remains high due to the hazardous chemical present.
What to Do
Stop using the recalled tablets immediately. Contact The Harvard Drug Group LLC or your healthcare provider for further guidance.
Contact Information
For more information, visit the FDA recall page at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0011-2026 or call The Harvard Drug Group LLC.